Assessing the severity of the novel influenza A/H1N1 pandemic
- 14 July 2009
- Vol. 339 (jul14 3) , b2840
- https://doi.org/10.1136/bmj.b2840
Abstract
A major concern about the emergence of the novel strain of influenza A/H1N1 is the severity of illness it causes. Tini Garske and colleagues propose methods to obtain accurate estimates of the case fatality ratio as the pandemic unfoldsKeywords
This publication has 11 references indexed in Scilit:
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- Deaths from Bacterial Pneumonia during 1918–19 Influenza PandemicEmerging Infectious Diseases, 2008
- Non‐parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS)Statistics in Medicine, 2006
- Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious DiseaseAmerican Journal of Epidemiology, 2005
- A Chain Multinomial Model for Estimating the Real-Time Fatality Rate of a Disease, with an Application to Severe Acute Respiratory SyndromeAmerican Journal of Epidemiology, 2005
- Risk of Myocardial Infarction and Stroke after Acute Infection or VaccinationNew England Journal of Medicine, 2004
- A Comparison Study of Realtime Fatality Rates: Severe Acute Respiratory Syndrome in Hong Kong, Singapore, Taiwan, Toronto and Beijing, ChinaJournal of the Royal Statistical Society Series A: Statistics in Society, 2004
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infectionsThe Lancet, 1998
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997